Aquaporin 2: From its discovery to molecular structure and medical implications
Tài liệu tham khảo
Barile, 2005, Large scale protein identification in intracellular aquaporin-2 vesicles from renal inner medullary collecting duct, Mol. Cell Proteomics, 4, 1095, 10.1074/mcp.M500049-MCP200
de Mattia, 2005, Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus, J. Am. Soc. Nephrol., 16, 2872, 10.1681/ASN.2005010104
Denker, 1988, Identification, purification, and partial characterization of a novel Mr 28,000 integral membrane protein from erythrocytes and renal tubules, J. Biol. Chem., 263, 15634, 10.1016/S0021-9258(19)37635-5
Eto, 2010, Phosphorylation of aquaporin-2 regulates its water permeability, J. Biol. Chem., 285, 40777, 10.1074/jbc.M110.151928
Finkelstein, 1986
Hasler, 2006, Tonicity-responsive enhancer binding protein is an essential regulator of aquaporin-2 expression in renal collecting duct principal cells, J. Am. Soc. Nephrol., 17, 1521, 10.1681/ASN.2005121317
Hoorn, 2008, Proteomic approaches for the study of cell signaling in the renal collecting duct, Contrib. Nephrol., 160, 172, 10.1159/000125981
Ishikawa, 2008, Pathophysiological role of aquaporin-2 in impaired water excretion, Prog. Brain Res., 170, 581, 10.1016/S0079-6123(08)00445-7
Kageyama, 1996, Water channel protein subtype suggests the origin of renal cell carcinoma, J. Urol., 156, 291, 10.1016/S0022-5347(01)66019-1
Kanno, 1995, Urinary excretion of aquaporin-2 in patients with diabetes insipidus, N. Engl. J. Med., 332, 1540, 10.1056/NEJM199506083322303
Lu, 2007, Heat shock protein 70 interacts with aquaporin-2 and regulates its trafficking, J. Biol. Chem., 282, 28721, 10.1074/jbc.M611101200
Martin, 1999, Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure, J. Am. Soc. Nephrol., 10, 2165, 10.1681/ASN.V10102165
Sasaki, 1994, Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct, J. Clin. Invest., 93, 1250, 10.1172/JCI117079
Schrier, 2006, Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia, N. Engl. J. Med., 355, 2099, 10.1056/NEJMoa065181
Smith, 1951
van Balkom, 2002, The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin-2 water channel, J. Biol. Chem., 277, 41473, 10.1074/jbc.M207525200